USTEKINUMAB vs VALGANCICLOVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
USTEKINUMAB vs VALGANCICLOVIR: Safety Overview
| Metric | USTEKINUMAB | VALGANCICLOVIR |
|---|---|---|
| Total FAERS Reports | 85,332 | 7,913 |
| Deaths Reported | 4,519 | 1,274 |
| Death Rate | 5.3% | 16.1% |
| Hospitalizations | 17,127 | 3,092 |
| Average Patient Age | 48.1 yrs | 48.8 yrs |
| % Female Patients | 60.3% | 41.2% |
| FDA Approval Date | N/A | Apr 11, 2023 |
| Manufacturer | SANDOZ INC | NorthStar RxLLC |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | Prescription | Prescription |